SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Pyxis Oncology to Present Phase 1 MICVO Data at EORTC-NCI-AACR Symposium

Pyxis Oncology says it will present Phase 1 monotherapy data for micvotabart pelidotin at the symposium.

PYXS

Related stories